de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535
Thenganatt MA, Jankovic J (2014) Parkinson disease subtypes. JAMA Neurol 71:499–504
Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590
Hayes MT (2019) Parkinson’s disease and parkinsonism. Am J Med 132:802–807
Massano J, Bhatia KP (2012) Clinical approach to Parkinson’s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2:a008870
Article PubMed PubMed Central Google Scholar
Herrero M-T, Estrada C, Maatouk L, Vyas S (2015) Inflammation in Parkinson’s disease: role of glucocorticoids. Front Neuroanat 9:32
Article PubMed PubMed Central Google Scholar
Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376
Article PubMed CAS Google Scholar
DeMaagd G, Philip A (2015) Parkinson’s Disease and its management: part 1: Disease Entity, Risk factors, pathophysiology, clinical presentation, and diagnosis. P T 40:504–532
PubMed PubMed Central Google Scholar
Rana AQ, Ahmed US, Chaudry ZM, Vasan S (2015) Parkinson’s disease: a review of non-motor symptoms. Expert Rev Neurother 15:549–562
Article PubMed CAS Google Scholar
Lee HM, Koh S-B (2015) Many faces of Parkinson’s Disease: non-motor symptoms of Parkinson’s Disease. J Mov Disord 8:92–97
Article PubMed PubMed Central Google Scholar
Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013
Aarsland D, Creese B, Politis M et al (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13:217–231
Article PubMed PubMed Central Google Scholar
Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27–42
Article PubMed CAS Google Scholar
Tibar H, El Bayad K, Bouhouche A et al (2018) Non-motor symptoms of Parkinson’s Disease and their impact on quality of life in a cohort of Moroccan patients. Front Neurol 9:170
Article PubMed PubMed Central Google Scholar
Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211
Ferreira N, Richner M, van der Laan A et al (2021) Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy. Brain Commun 3:fcab104
Article PubMed PubMed Central Google Scholar
Taylor KI, Sambataro F, Boess F et al (2018) Progressive decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: an analysis of longitudinal Parkinson progression markers Initiative Diffusion Tensor Imaging Data. Front Aging Neurosci 10:318
Article PubMed PubMed Central CAS Google Scholar
Shih Y-C, Tseng W-YI, Montaser-Kouhsari L (2022) Recent advances in using diffusion tensor imaging to study white matter alterations in Parkinson’s disease: a mini review. Front Aging Neurosci 14:1018017
Basser PJ, Mattiello J, LeBihan D (1994) MR diffusion tensor spectroscopy and imaging. Biophys J 66:259–267
Article PubMed PubMed Central CAS Google Scholar
Jiang Y, An H, Xi Q et al (2022) Diffusion Tensor Imaging reveals deep brain structure changes in early Parkinson’s Disease patients with various Sleep disorders. Brain Sci 12. https://doi.org/10.3390/brainsci12040463
Shih Y-C, Ooi LQR, Li H-H et al (2023) Serial deep gray nuclear DTI changes in Parkinson’s disease over twelve years. Front Aging Neurosci 15:1169254
Article PubMed PubMed Central Google Scholar
Sanjari Moghaddam H, Dolatshahi M, Mohebi F, Aarabi MH (2020) Structural white matter alterations as compensatory mechanisms in Parkinson’s disease: a systematic review of diffusion tensor imaging studies. J Neurosci Res 98:1398–1416
Article PubMed CAS Google Scholar
Zhang Y, Burock MA (2020) Diffusion Tensor Imaging in Parkinson’s Disease and Parkinsonian Syndrome: a systematic review. Front Neurol 11:531993
Article PubMed PubMed Central Google Scholar
Prasuhn J, Heldmann M, Münte TF, Brüggemann N (2020) A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets. Neurol Res Pract 2:46
Article PubMed PubMed Central Google Scholar
Hall DA, Moore C, Comella C, SPARX Study Group (2018) Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial. Trials 19:630
Article PubMed PubMed Central Google Scholar
Marek K, Jennings D, Lasch S et al (2011) The Parkinson progression marker Initiative (PPMI). Prog Neurobiol 95:629–635
Article PubMed Central Google Scholar
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Article PubMed PubMed Central CAS Google Scholar
Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312
Stiasny-Kolster K, Mayer G, Schäfer S et al (2007) The REM sleep behavior disorder screening questionnaire–a new diagnostic instrument. Mov Disord 22:2386–2393
Buysse DJ, Reynolds CF 3rd, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Article PubMed CAS Google Scholar
Spielberger CD (1989) State-trait anxiety inventory: bibliography, 2nd edn. Palo Alto
Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontologist: J Aging Mental Health 5:165–173
Weintraub D, Saboe K, Stern MB (2007) Effect of age on geriatric depression scale performance in Parkinson’s disease. Mov Disord 22:1331–1335
Article PubMed PubMed Central Google Scholar
Weintraub D, Oehlberg KA, Katz IR, Stern MB (2006) Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 14:169–175
Article PubMed PubMed Central Google Scholar
Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170
Comments (0)